Strategy to improve the request of uric acid in primary care: Preliminary results and evaluation through process and outcome appropriateness indicators

Clinical Biochemistry

Volumn 47, Issue 6, 2014, Pages 467-470

  Salinas, Maria ^a,b   López Garrigós, Maite ^a   Asencio, Alberto ^c   Batlle, Enrique ^a   Minguez, Mauricio ^a   Lugo, Javier ^a   Salinas, Elías ^a   Leiva Salinas, Carlos ^d  

^a HOSPITAL UNIVERSITARIO DE SAN JUAN   (Spain)

^b MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^c Primary Care Center of Mutxamel   (Spain)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Appropriateness; Gout; Hyperuricemia; Laboratory management; Patient safety; Test request; Uric acid

Indexed keywords

ALLOPURINOL; GLUCOSE; URIC ACID; GLUCOSE BLOOD LEVEL;

ARTICLE; DEMOGRAPHY; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT SAFETY; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; EVALUATION STUDY; GLUCOSE BLOOD LEVEL; HEALTH STATUS INDICATOR; METABOLISM; PRIMARY HEALTH CARE;

ALLOPURINOL; BLOOD GLUCOSE; EVALUATION STUDIES AS TOPIC; HEALTH STATUS INDICATORS; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PRIMARY HEALTH CARE; URIC ACID;

EID: 84897108304     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.12.025     Document Type: Article

References (10)

1. Álvarez-Lario B., Macarrón-Vicente J. Uric acid and evolution. Rheumatology 2010, 49:2010-2015.
2. Kono H., Chen C.J., Ontiveros F., Rock K.L. Uric acid promotes an acute inflammatory response to sterile cell death in mice. J Clin Invest 2010, 120:1939-1949.
3. Salinas M., López-Garrigós M., Díaz J., Ortuño M., Yago M., Laíz B., et al. Regional variations in test requiring patterns of general practitioners in Spain. Ups J Med Sci 2011, 116:247-251.
4. Van Walraven C., Naylor C.D. Do we know what inappropriate laboratory utilization is? A systematic review of laboratory clinical audits. JAMA 1998, 280:550-558.
5. Larsson A. What can we learn from studies on regional differences in the utilization of laboratory tests?. Ups J Med Sci 2011, 116:225-226.
6. Chao J., Terkeltaub R. A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout. Curr Rheumatol Rep 2009, 11:135-140.
7. Moloney T.W., Rogers D.E. Medical technology: a different view of the contentious debate over costs. N Engl J Med 1979, 301:1413-1419.
8. Salinas M., Lopez-Garrigós M., Flors L., Leiva-Salinas C. Laboratory false-positive results: a clinician responsibility or a shared responsibility with requesting clinicians?. Clin Chem Lab Med 2013, 51:e199-e200.
9. Salinas M., López-Garrigós M., Leiva-Salinas C. False positive results: the imaginary invalid syndrome. Aten Primaria July 16 2013, [pii:S0212-6567(13)00154-6]. 10.1016/j.aprim.2013.04.010.
10. The laboratory in diagnosis. JAMA 1907, 48:63-70. [Reprinted in JAMA 100 years ago, JAMA 2007;297:538].